Cite
HARVARD Citation
Tusa, I. et al. (n.d.). MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes. European journal of cancer. pp. S174-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tusa, I. et al. (n.d.). MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes. European journal of cancer. pp. S174-. [Online].